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Abstract
Background: Melanin synthesis, the elective trait of melanocytes, is regulated by tyrosinase activity. In tyrosinase-
positive amelanotic melanomas this rate limiting enzyme is inactive because of acidic endo-melanosomal pH. The E5
oncogene of the Human Papillomavirus Type 16 is a small transmembrane protein with a weak transforming activity and
a role during the early steps of viral infections. E5 has been shown to interact with 16 kDa subunit C of the trans-
membrane Vacuolar ATPase proton pump ultimately resulting in its functional suppressions. However, the cellular effects
of such an interaction are still under debate. With this work we intended to explore whether the HPV16 E5 oncoprotein
does indeed interact with the vacuolar ATPase proton pump once expressed in intact human cells and whether this
interaction has functional consequences on cell metabolism and phenotype.
Methods:  The expression of the HPV16-E5 oncoproteins was induced in two Tyrosinase-positive amelanotic
melanomas (the cell lines FRM and M14) by a retroviral expression construct. Modulation of the intracellular pH was
measured with Acridine orange and fluorescence microscopy. Expression of tyrosinase and its activity was followed by
RT-PCR, Western Blot and enzyme assay. The anchorage-independence growth and the metabolic activity of E5
expressing cells were also monitored.
Results: We provide evidence that in the E5 expressing cells interaction between E5 and V-ATPase determines an
increase of endo-cellular pH. The cellular alkalinisation in turn leads to the post-translational activation of tyrosinase,
melanin synthesis and phenotype modulation. These effects are associated with an increased activation of tyrosine
analogue anti-blastic drugs.
Conclusion: Once expressed within intact human cells the HPV16-E5 oncoprotein does actually interact with the
vacuolar V-ATPase proton pump and this interaction induces a number of functional effects. In amelanotic melanomas
these effects can modulate the cell phenotype and can induce a higher sensitivity to tyrosine related anti-blastic drugs.
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Background
Human Papillomavirus type 16 (HPV-16) is a member of
species 9 of the mucosotropic α Papillomavirus genus.
Together with a further fifteen α Papillomavirus types,
HPV16 is comprised within the so called High Risk ano-
genital HPV (HR-HPV), that are causally involved in the
development of malignant tumors [1]. In particular, HPV
16 is the major etiological agent for cervical cancer[2] and
it has also been implicated as a causative agent in a
number of carcinomas originating from a variety of other
anatomical sites. The oncogenic potentials of HR-HPV
types depend on the activity of three transforming genes:
E5, E6, and E7. The E6 and E7 proteins are unanimously
recognized as the major responsible for virus carcino-
genicity [3-5]. Conversely, E5 has been found to have only
weak transforming properties and accessory functions [6-
8] although indirect evidences point to E5 as an hallmark
of HR-HPVs carcinogenicity [9,10].
HPV-16 E5 is a highly hydrophobic membrane protein,
83 amino acids long, located mainly at the Endoplasmic
Reticulum (ER) and to a lesser extent on the Golgi appa-
ratus, the plasma membranes and early endosomes [11].
Its expression induces several cellular changes, including
enhanced growth factor signalling [12], the activation of
mitogen-activated protein kinase pathways [13], anchor-
age independent growth in immortalized fibroblasts [14],
down regulation of MHC Class I and Class II molecules
[15,16]. Despite the above wide range of activities and in
contrast to E5 of Bovine Papillomavirus 1 – one of the first
PV oncoproteins to be identified and known as the main
oncogene – the biological activities of the HPV16 E5 pro-
tein still remain poorly characterized and its role in HPV
pathogenesis is far to be understood [17]
While biochemical interaction of the E5 oncoprotein with
the vacuolar H+-ATPase (V-ATPase) is well accepted the
cellular effects of this interaction are still under debate.
The V-ATPase, the universal proton pump of eukaryotes,
is a major modulator of endoplasmic and endosomal pH
and through this modulation it regulates the organellar
trafficking and functions. It is known that the E5 protein
of HPV-16 can interact with the 16 kDa subunit C of the
proton pump [11-18] within the ER where most of the E5
is found. Such an interaction prevents the Subunit C from
participating in the assembly of the Vacuolar Subcomplex
(V0 Subcomplex) that is required for the formation of the
mature V-ATPase on the vacuolar membranes [19]. This
significantly delays the proteolytic endosomal degrada-
tion of the internalized EGFr that eventually recycles to
the plasma membrane. This extend the EGFr lifespan and
increases the EGF dependent/EGFr signalling [20,21] sug-
gesting that the interaction with the subunit C represent
an elective function of E5. Conversely, other authors
believe that the impairment of V-ATPase and consequent
delayed degradation of internalized EGFr is an indirect
result of trafficking disruption and impaired fusion of
early endosomes with late acidic endosomes [22,23]. The
pH modulation is very important in the regulation of cell
organellar trafficking and function in many cellular
strains. In particular intra-melanosomal pH has been
indicated as an essential factor for the control of melanin
deposition in melanocytes [24]. Melanogenesis is regu-
lated through the modulation of tyrosinase, the rate-lim-
iting enzyme of the melanogenic pathway. Differences in
tyrosinase activity of melanocytes from different skin
photo types (Caucasian or Black skin) have been reported
[25]. It has also been shown that these differences were
not due to variations in tyrosinase abundance or gene
activity, but to the regulation of catalytic activity of the
enzyme [25]. In fact, near neutral melanosomal pH is
optimal for human tyrosinase activity and melanogenesis
while melanin production is suppressed in Caucasian
melanocytes by low melanosomal pH [24]. Accordingly,
tyrosinase mRNA and tyrosinase protein are actually
present also in amelanotic melanomas, where no tyrosi-
nase activity and no melanin deposition can be detected
[26,27]. The probable reason of the declined catalytic
activity in these cells, where tyrosinase is present in a inac-
tive state, is the low internal pH due to elevated V-ATPase
activity consequent to elevated glycolysis and extra-cellu-
lar acidification occurring during the metastatic spread.
Accordingly, it has been demonstrated that substances
that act as selective inhibitors of V-ATPase [28,29] are able
to determine the re-activation of tyrosinase and melano-
genesis and melanotic reversion of amelanotic melano-
mas [26].
In the present work we expressed the HPV 16 E5 protein
in two lines of human, tyrosinase-positive, amelanotic
melanomas with the aim to examine whether the E5
expression could modulate the melanosomal pH and
tyrosinase activity. Here we provide evidence that HPV-16
E5 protein inhibits proton pump, causing alkalinisation
of endocellular pH, tyrosinase activation, melanin depo-
sition and modulation of sensitivity to dopamine mimetic
drugs.
Methods
Materials
Concanamycin A (ConA), 3- [4,5-dimethylthiazol-2-yl]-
2,5-diphenyl tetrazolium bromide (MTT), 3,4-dihydroxy-
benzylamine (DHBA) and buthionine sulfoximine (BSO)
were purchased from Sigma Chemical Co. (St. Louis, MO,
USA). [3H] tyrosine was purchased from Amersham Bio-
sciences Ltd, Amersham UK). Dulbecco's modified Eagle's
medium (DMEM), RPMI 1640 medium and foetal bovine
serum (FBS) were purchased from Invitrogen SRL (San
Giuliano Milanese, Italy), as well as the SuperScript One-
Step RT-PCR System with Platinum Taq DNA Polymerase.Journal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
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The LZRSpBMNZ and the LZRSpBMNZ-E5 plasmids were
kindly provided by G. Sibbett (The Beatson Institute for
Cancer Research, Glasgow, UK) [30]. All other reagents
were analytical grade products.
Cell cultures
Two established cell lines of human melanoma, kindly
provided by Dr. G. Zupi (Laboratory of Chemotherapy,
Regina Elena Institute for Cancer Research, Rome, Italy),
were used in the present study: FRM and M14. FRM was
recently established from a melanoma patient while M14
is a long established melanoma cell line. Cells were grown
in RPMI 1640 medium with 10% (v/v) FBS in humidified
incubator with 5% CO2 at 37°C and sub-cultured twice a
week at 1:3 and 1:5 split ratio for FRM and M14, respec-
tively. For ConA treatment, cells were seeded at 3.0 × 104
cell/cm2  and allowed to attach overnight. The culture
medium was then discarded and replaced with fresh
medium containing 10 nM ConA and cells incubated for
a further 24 h before the assays.
Phoenix A cells [31] is a producer cell line for the genera-
tion of helper free ecotropic retroviruses. Derived from the
293T Human embryonic kidney line, Phonenix A are
highly transfectable using either calcium phosphate or
lipid-based transfection protocols and allow the produc-
tion of infectious progeny within a few days. The presence
of an IRES-CD8 surface marker expression cassette down-
stream of the reading frame of the gag-pol construct offers
the advantage to monitor the stability of the producer cell
population's ability to produce the gag-pol proteins. Most
importantly, both gag-pol and env constructs are under
different non Moloney promoters thus minimizing the
recombination potential with the introduced retroviral
construct. Phoenix A cells were grown in High Glucose
DMEM medium supplemented with 10% FBS. Cells were
never allowed to reach confluency and were passaged
twice a week at a 1:4/1:5 split ratio.
Transfection procedure
Phoenix A cells were harvested by trypsinization and
replated at 3,3 × 104 cell/cm2 in T-75 flasks in complete D-
MEM. After 24 h the medium was changed with 13.6 ml
of complete D-MEM containing 25 μM Cloroquine
diphosphate and the cells were incubated for 30 min at
37°C. At the same time, the DNA Calcium Phosphate co-
precipitate mixture was prepared (i.e.: 30 μg of either LZR-
SpBMNZ or LZRSpBMNZ-E5 plasmid in 0.7 ml 0.25 M
CaCl2, successively added with 0.7 ml 50 mM N,N-bis (2-
hydroxyethyl)- 2-aminoethansulfonic acid). After 30 min
at room temperature, the 1.4 ml Calcium Phosphate mix-
tures were slowly added to the flasks under delicate agita-
tion. After a 12 h incubation at 37°C in a 5% CO2
atmosphere, the medium was removed, the cells washed
once with PBS, added with fresh complete D-MEM and
incubated at 32°C with 5% CO2 for 48 h. The medium
containing the E5 bearing – or the empty, negative con-
trol, -retroviral progenies were removed and centrifuged at
1000 × g for 10 min to pellet cell debris. Clarified super-
natant were harvested and either used immediately for
infection or aliquoted and stored at -80°C for later use.
Infection procedure
24 h before infection, melanoma cells were harvested and
replated at 2.0 × 104 cell/cm2 into T-25 flasks. The infec-
tion mixtures were prepared by adding 1.5 ml of D-MEM
containing either the E5 retrovirus or the empty retrovirus
with 1.5 ml of complete D-MEM. Polybrene (5 μg/ml)
was then added to each flask directly at the moment of
infection. Flasks were then centrifuged at 190 × g for 30
min at room temperature and incubated for 24 h at 32°C
in a 5% CO2 atmosphere. The medium was then changed
with fresh, complete D-MEM and the cells incubated at
37°C with 5% CO2  for further 48 h. Surviving cells,
roughly 40% of the challenged cells, were then washed
twice with PBS and replated at 2 × 104 cell/cm2. The effi-
ciency of infection procedure was measured in a pilot
experiment by a dilution limit PCR strategy showing an
almost even end point for E5 and the single copy beta-
globin reference sequence (data not shown). This finding
is compatible with an above 50% infection of target cells
carrying 1 to 10 copies of proviral DNAs and is in tune
with the results expected on the basis of theoretical con-
siderations. The presence of the proviral E5 DNA and of
the E5 specific mRNA was confirmed by PCR and RT-PCR
as below described. Cells infected with the control retrovi-
rus were briefly referred to as "control cells" throughout
the paper.
PCR and RT-PCR
Analyses were performed as previously described [27].
Total DNA and RNA were simultaneously extracted from
exponentially growing cell cultures by the Tri-Reagent
commercial kit (Molecular Research Centre, Cincinnati,
OH) used according to the supplier's instruction. The
quality of RNAs was evaluated by the A260/A280 ratio and
by visual inspection of ethidium bromide stained forma-
mide agarose gel electrophoresis under UV-B trans-illumi-
nation. 1 μg of DNAse digested total RNA and 0.2 μg DNA
were amplified in a 50 μl volume of Superscript One-Step
(RT)-PCR Platinum TAQ reaction mixture completed with
500 nM up-stream and down-stream primers and 1.5 mM
Mg2+. For RT-PCR, the reverse transcription was carried
out at 45°C for 30 min. Samples were then heated to
95°C for 150 s to inactivate reverse transcriptase and to
activate Platinum TAQ Polymerase. Amplification con-
sisted in 35 cycles under the following conditions. For E5:
annealing at 94°C for 50 s, extension at 45°C for 50 s and
denaturation at 72°C for 60 s and a final cycle with a 10
min long extension. DNA digested non retrotranscribedJournal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
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negative controls were maintained at +4°C during the RT
step and placed in the thermal amplifier at the beginning
of RT inactivation step (95°C for 150 s). For tyrosinase:
annealing at 52°C for 30 s, extension at 73°C for 60 s and
denaturation at 95°C for 45 s and a final cycle with a 5
min long extension. For E5 the E5P65 sense (TGC ATC
CAC AAC ATT ACT GGC G) and E5M3AS antisense (AAC
ACC TAA ACG CAG AGG CTG C) primers were used; for
human tyrosinase the primers were Hu-TYR1 (TTG GCA
GAT TGT CTG TAG CC) and Hu-TYR2 (AGG CAT TGT
GCA TGC TGC TT) as suggested by Calogero et al. [32].
Cell viability, cell proliferation and cell specific metabolic 
activity
Cell viability was measured as already described [27],
Briefly, cells were seeded in 96-well microplates at a den-
sity which allowed an exponential growth rate for the fol-
lowing 5 day incubation (i.e. 1.0 × 104/well for M14 and
1.6 × 104/well for FRM). At 24 h intervals the cells were
challenged with 1.25 mg/ml MTT in a 100 μl volume of
fresh medium containing 0.1% FBS [33]. After 2 h of incu-
bation the monolayers were then decanted, washed twice
with PBS and the reduced insoluble dye eluted by 100 μl
of isopropanol/HCl 0.04 N. The cell viability was then
assessed through the MTT reducing activity evaluated by
the A540 – A750 difference measured by a microplate reader
(Labsystem Multiscan MS – Thermo Fisher Scientific, Inc.
Waltham MA).
Cell proliferation was measured by the growth curve as
already described [34]. Briefly, cells were seeded in 96-
well microplates at the same density as above. At 24 h
intervals the monolayers were stained with Crystal Violet
(CV), the dye was eluted by means of 33% acetic acid and
the cell number in each well was estimated by the A540
measured in a microplate reader (Labsystem).
Considering that cell viability assay does actually measure
the total reducing activity within a tissue culture, and con-
sidering that such a global activity may largely vary
according to culture conditions, cell environment and
phenotypic status, to gain information about a possible
modulation of the metabolic activity within E5 expressing
cells, the cell specific metabolic activity was calculated.
This is the simple MTT/CV absorbance ratio, expressed in
arbitrary units, and gives information about the average
metabolic activity of single cells.
For each assay a set of at least four different experiment
was considered. Each experiment consisted of eight inde-
pendent replicas.
Acridine orange fluorescent staining
To visualize acidic organelles, Acridine orange (AO) was
used [35]. AO is a fluorescent probe that emits green at
low concentration and orange at high concentration. To
determine the effect of treatments on endocellular com-
partment pH, cell cultures were seeded onto multiwell
microscope slides and allowed to attach overnight. The
culture medium was then replaced with non supple-
mented medium or medium containing 10 nM ConA or
medium containing the retrovirus. After 24 h, AO (5 μg/
ml) was added and incubation continued for another 20
min. The slides were fixed with 2% formaldehyde in PBS
and processed for fluorescence microscopy with a Zeiss
466301 microscope. An Olympus Camedia C5060 was
used for colour photography.
Anchorage independent growth assay
A 2 ml of 0.5% agarose gel in RPMI at 10% FCS was
poured in each 35 mm well of a plastic plate and allowed
to solidify at room temperature for 2 hours in a laminar
flow hood. Then a 0.5 ml of a 0.33% agarose gel contain-
ing 250 cells was overlaid on top, allowed to stand for 30'
at +4°C and subsequently incubated at 37°C. After a 12–
16 days incubation the cell growth was evaluated by
bright field observation under low magnification and
growing colonies photographed.
Western blot analysis
Immunoblot analysis was performed as previously
described [36]. Cell lysis was carried out at 4°C by sonica-
tion for 1 min in Media I (0.32 M sucrose, 10 mM Tris-
HCl, pH 8.0, 0.1 mM MgCl2, 0.1 mM EDTA, 1 mM phe-
nyl-methyl-sulfonyl-fluoride (PMSF) and 10 μg/ml apro-
tinine) and lysates were stored at -70°C until use. Protein
content was determined by the Bio-Rad Protein Assay
(Bio-Rad Laboratories Srl, Segrate, Italy). Proteins were
separated by 12% SDS-PAGE and transferred to PVDF
membranes in 25 mM Tris, 92 mM glycine containing
20% (v/v) methanol at 110 V for 1 h. Following transfer,
membranes were placed for 1 h in blocking buffer (bovine
serum albumin 3% in T-TBS). For tyrosinase detection,
membranes were probed first with 10 ml of blocking
buffer containing goat anti-tyrosinase polyclonal anti-
body (Santa Cruz Biotechnology Inc., CA) (1:500) for 1 h
at 27°C, followed by 10 ml of blocking buffer containing
horseradish peroxidase-conjugated rabbit anti-goat IgG
(1:5000) for 60 min at 27°C. Protein bands were visual-
ized using luminol-based enhanced chemo-luminescence
as described by the manufacturer (Perkin-Elmer Life Sci-
ences). Densitometric analysis was performed using Scion
Image (PC version of Macintosh-compatible NIH Image).
Tyrosinase activity assay
Cell monolayers were treated with trypsin/EDTA; suspen-
sions washed with PBS and pellets recovered by centrifu-
gation at 250 × g  for 10 min. Cells were lysed by
sonication (six times for 5 seconds each) in 0.5 ml of 0.1
M Na-phosphate buffer, pH 6.8, containing 0.1 mMJournal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
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PMSF. After centrifugation at 7,000 × g for 10 min, tyrosi-
nase activity was assayed on supernatant according to
Iozumi et al. [37]. Fifty μl of sample was incubated in 0.5
ml of a reaction mixture containing 0.1 mM L-tyrosine, 2
μCi per ml of [3H] tyrosine, 0.1 mM L-DOPA and 0.1 mM
PMSF in sodium phosphate buffer 0.1 M (pH 6.8). After 2
h at 37°C, the reaction was terminated by the addition of
1 ml of charcoal (10% wt/vol in 0.1 N HCl). Samples were
centrifuged at 2000 g for 10 min, the supernatant was
removed and mixed with scintillation cocktail, and radio-
activity was determined using the LS 6500 scintillation
system (Beckman, U.S.A.).
Treatment with cytotoxic agents
Cells were incubated with 30 μM DHBA or BSO in RPMI
1640 medium with 10% (v/v) FBS in humidified incuba-
tor with 5% CO2 at 37°C. After 48 h incubation cell via-
bility was determined by MTT method, as previously
described.
Statistical analysis
For tissue culture assays a set of at least four different
experiment was performed and each data point within
any single experiment is the mean (± SD) of eight inde-
pendent replicas. P values for cell proliferation and cell
viability were calculated respect to the corresponding
value T = 0. the normal data distribution among samples
was assessed by the Shapiro – Wilk test and the Parametric
(T Student) or non-Paramentric (Mann-Whitney) test
were used accordingly. Standard deviations (SD) were
reported for cell specific activity ratios and for the relative
tyrosinase expression.
Results
The isolated E5 HPV 16 oncogene can be expressed in 
melanoma cells
HPV 16 E5 is a small hydrophobic molecule expressed at
very low levels in keratinocytes at early stages during viral
infection and appearing to be critically linked to viral
pathogenic potentials. Two amelanotic melanoma cell
lines, FRM and M14, were infected with a HPV 16 E5
expressing retroviral vector and compared with the same
lines infected with an "empty" retrovirus. After the infec-
tion with the E5 retroviral construct, the presence of cDNA
for the E5 oncogene, as well as the corresponding mRNA,
was shown by PCR and RT-PCR both in M14 and FRM
cells (Fig. 1). Subsequently we investigated whether the E5
oncogene can be tolerated in these cells. Despite the high
hydrophobic structure of the E5 protein would suggest a
rather toxic effect, the expression of this viral oncogene
had almost no effect on cell morphology (data not
shown), cell proliferation and cell viability, while a clear
increase of the cell specific metabolic activity (more evi-
dent in FRM than in M14) was seen in E5 expressing cells
(Fig. 2). These characteristics were rather stable being
Presence of HPV-16 E5 DNA and expression of the specific  mRNA in M14 and FRM cells after infection with HPV-16 E5  retroviral vector Figure 1
Presence of HPV-16 E5 DNA and expression of the 
specific mRNA in M14 and FRM cells after infection 
with HPV-16 E5 retroviral vector. The retroviral vector 
containing HPV-16 E5 gene was obtained by the transfection 
of Phoenix A retroviral producer cells with the LZRSpB-
MNZ-E5 plasmid. The control retroviral vector was obtained 
by the transfection of Phoenix cells with the empty LZRSpB-
MNZ plasmid. Cells were infected with either recombinant 
retrovirus or with the control retrovirus. Total DNA or 
RNA (1 μg) extracted from cells 96 h post infection were 
reverse transcribed and amplified with E5P65 sense (TGC 
ATC CAC AAC ATT ACT GGC G) and E5M3AS antisense 
(AAC ACC TAA ACG CAG AGG CTG C) primers. Upper 
panel: FRM cells; Lower panel: M14 cells. Lane 1: DNA from 
cells infected with the control retrovirus; Lane 2: DNA from 
cells infected with the HPV-16 E5 retrovirus; Lane 3: DNA 
digested total RNA from cells infected with the HPV-16 E5 
retrovirus; Lane 4: Non retrotrascribed DNA digested total 
RNA from cells infected with the HPV-16 E5 retrovirus; Lane 
5: No template negative control; Lane 6 positive control (0.5 
μg Siha cell DNA). MW: DNA molecular weight marker VIII 
(Roche Biochemicals SpA): arrows on the left-hand side indi-
cate the bp length of some reference bands. The band with 
size of 160 bp (left sided empty arrow) demonstrate the 
presence of viral E5 sequence and its transcription. Four 
independent experiments gave similar results.Journal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
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Effect of HPV-16 E5 expression on the proliferation, cell viability and on cell specific metabolic activity of M14 and FRM  melanoma cells Figure 2
Effect of HPV-16 E5 expression on the proliferation, cell viability and on cell specific metabolic activity of M14 
and FRM melanoma cells. Cell proliferation (upper row) was slightly decreased in E5 expressing cells (empty symbols) as 
compared with control cells (full symbols). The cell viability of E5 expressing cells and control cells is shown in the middle row. 
The cell specific activity of E5 expressing cells (lower row) was higher than that of control cells. This effect, sharply evident in 
FRM cells appeared slighter in M14 and indicates an increased oxidative metabolism in E5 expressing cells. Values are the mean 
± S.D. of eight independent replicas and are derived from a representative experiment in a set of four. Statistical comparison of 
E5 expressing cells was made using either parametric (Student's t-test) or non paramentric (Mann – Whitney test) according to 
the results of the Shapiro – Wilk assay. (* = p < 0.05; ** = p < 0.005). The specific metabolic activities are calculated as the sim-
ple cell viability/cell proliferation ratio (MTT/CV ratio) and are expressed in arbitrary units as the mean of four different exper-
iments ± SD.
M14
0 24 48 72
0.0
0.2
0.4
0.6
0.8
1.0 M14 CTR
M14 + E5
A
5
4
0
FRM
0 24 48 72
0.0
0.2
0.4
0.6
0.8
1.0 FRM CTR
FRM + E5
0 24 48 72
0.0
0.2
0.4
0.6
0.8
1.0
M14 CTR
M14 + E5
A
5
4
0
-
 
A
7
5
0
0 24 48 72
0.0
0.2
0.4
0.6
0.8
1.0 FRM CTR
FRM + E5
0 24 48 72
0.0
0.2
0.4
0.6
0.8
1.0 M14 CTR
M14 + E5
Time (h)
A
.
 
U
.
0 24 48 72
0.0
0.4
0.8
1.2
1.6
2.0 FRM CTR
FRM + E5
Time (h)
Cell proliferation
Cell viability
Specific metabolic activity
** **
**
**
**
*
*
*
*
*
* *Journal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
Page 7 of 12
(page number not for citation purposes)
observed in both cell lines as far as the HPV 16 E5 onco-
gene was retained (at least 4–6 passages in vitro). Taken
together these data indicate that the isolated HPV 16 E5
oncogene can be expressed in amelanotic melanomas and
that its expression, devoid of any immediate gross cell tox-
icity, induces the fine modulation of selective cell activi-
ties.
E5 expression modulates endosomal pH and restores 
tyrosinase activity
Being well accepted the biochemical interaction of E5
with the V-ATPase proton pump, we investigated if the
infection with E5 could determine pH changes in FRM
and M14 cells. The fluorescent stain Acridine Orange
(AO) used for analysis is an acidotropic weak base which
is taken up by living cells and accumulates in acidified
compartments such as lysosomes, and melanosomes.
When AO accumulates at high concentrations in acidic
environment the fluorescence is orange; while at low con-
centration AO emits green [33]. The effect of E5 expres-
sion on endosomal pH is shown in Fig. 3. In E5 expressing
cells (+E5), the replacement of orange fluorescence with
green fluorescence indicated the raise of intracellular pH
with respect to control cells. The addition of the proton
pump inhibitor Con-A, a recognised alkalinizing agent, to
control cells determined a similar colour change of fluo-
rescence indicating that alkalinisation occurred. In both
cases the colour change of fluorescence staining was par-
ticularly evident in FRM cells.
The alkalinisation of endocellular compartments in the
E5 expressing cells was accompanied by the ability to sur-
vive in anchorage independent conditions and by a mild
deposition of pigment (Fig. 4). These two characteristics
are typical of melanomas growing in well oxygenated con-
texts while totally absent in control cells and in melano-
mas growing in hypoxic conditions (e.g. during metastatic
growth within compact tissues) [38,39]. Thus following
E5 expression and pH modulation the whole melanin
synthesis pathway was reactivated indicating a partial
reversion of the melanomas phenotype.
The tyrosinase activity in E5 expressing or Con A-treated
FRM and M14 cells was then determined. As seen in figure
5 the enzyme activity was clearly evident in both E5 cell
lines as well as in ConA treated cells, while no activity, as
Effect of HPV-16 E5 expression on intracellular pH in FRM and M14 melanoma cells Figure 3
Effect of HPV-16 E5 expression on intracellular pH in FRM and M14 melanoma cells. Cells infected with the con-
trol retrovirus (CTR), cells treated with 20 nM Con-A (+ ConA) or cells expressing the HPV-16 E5 (+ E5), were stained with 
AO as described. The loss of orange fluorescence and the appearance of green fluorescence in cells treated with ConA or 
expressing E5 indicate the alkalinisation of endocellular organelles. A representative experiment in a set of four.Journal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
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expected was detected in control cells. The rise of enzyme
activity was more pronounced in FRM than M14 cells and
considerably higher in E5 expressing than in ConA-treated
cells.
The expression of HPV 16 E5 oncogene does not modulate 
tyrosinase mRNA nor protein levels
In order to understand if the onset of melanotic pheno-
type and tyrosinase activation following the E5 expression
depends on a modulation of tyrosinase transcription and/
or protein expression, we determined the tyrosinase
mRNA and protein levels by RT-PCR and by Western Blot
(WB) analyses, respectively. Figure 6 shows that the
expression of E5 oncogene had no effect on tyrosinase
mRNA levels both in M14 and FRM cells and confirmed
that in these cell lines the amelanotic phenotype is associ-
ated with a fair transcription of tyrosinase mRNA [27].
Moreover, WB analysis showed that tyrosinase protein
levels were not modulated in E5 expressing cells in com-
parison with controls. These results, while confirming the
poor connection between pigmentation genes expression
and the pigmentary status of melanomas, indicate that the
amelanotic phenotype of FRM and M14 cells is indeed
related to post-translational regulatory process in melano-
cytes that express normal amounts of tyrosinase protein.
The tyrosinase reactivation could be exploited as a target 
for the development of selective chemotherapeutic agents
Subsequently we wondered whether the above reported
endosomal alkalinisation and the reactivation of tyrosi-
nase was associated with modifications in cell phenotype
eventually resulting in an altered susceptibility to chemo-
therapeutic agents. Based on the notion that 3,4-DHBA, a
dopamine mimetic pro-drug, is a substrate for tyrosinase
with consequent production of toxic intermediates [40]
we evaluated its cytotoxic effect in E5 expressing cells. Fig.
7 shows that a 30 μM concentration induced a much
stronger impairment of cell viability on E5 expressing
melanomas than on the control cells. The same figure
shows also that BSO, a well-known inhibitor of glutath-
ione synthesis whose cytotoxic effects are correlated with
the level of tyrosinase activity [40], determined a drastic
reduction of cell viability in E5 expressing cells, while con-
trol cells were scarcely affected.
Discussion
Pigment deposition takes place in specialized organelles,
the melanosomes. In these organelles a number of specific
proteins are expressed. Interestingly each of these proteins
represents a unique feature of melanocytes and a potential
target for the development of selective therapies or elec-
tive diagnostic methods for the malignant melanoma
[41,42]. Regulation of melanogenesis at transcriptional
level is mostly controlled by the microphtalmia transcrip-
tion factor, however the amelanotic phenotype may also
result from post-translational mechanisms in cells
expressing normal amounts of pigmentary proteins. This
regulatory level has been shown to be important in deter-
mining skin and hair colour and pigmentary phenotype
of malignant melanomas [37,24].
The fast growing incidence of malignant melanomas in
the last decades coupled with the lack of satisfactory treat-
ments for advanced melanomas underline the urgency for
a better understanding of their biology and greatly stimu-
Effect of HPV-16 E5 expression on tyrosinase activity and  pigment deposition and anchorage independent growth of  amelanotic melanomas Figure 4
Effect of HPV-16 E5 expression on tyrosinase activity 
and pigment deposition and anchorage independent 
growth of amelanotic melanomas. Colony formation 
under anchorage independent culture conditions. The E5 
expressing FRM cells displayed a moderated colony forma-
tion activity and a variable degree of pigment deposition 
while no colony nor pigmentation could ever been shown 
among control parental cells. Similar results were shown 
with M14 cells (data not shown). A representative experi-
ment in a set of 3.
                          FRM  CTR 
                         FRM + E5 Journal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
Page 9 of 12
(page number not for citation purposes)
lated research in this area. To investigate the possibility to
modulate the biological behaviour of amelanotic melano-
mas through the modulation of the organellar pH, we
expressed the HPV 16 E5 oncogene in the FRM and M14
cells and evaluated the implications of such an expression
on the cell phenotype. Both are amelanotic cell lines
expressing normal levels of tyrosinase maintained in an
inactive state by the acidic endosomal pH, as demon-
strated by the tyrosinase restoration following the selec-
tive inhibition of the V-ATPase by ConA treatment.
The HPV 16 E5 oncogene is a small, highly hydrophobic
protein of 83 aminoacids that localizes in endocellular
membrane and exhibits only weak transforming activity
[6,43]. Within the context of the viral genome it has the
function of enhancing the ligand dependent EGF Receptor
activation [12] thus resulting in a longer persisting, higher
producing viral infection. Once expressed as isolated pro-
tein, E5 is mostly found in the endoplasmic reticulum
(ER) membranes and at a much lower abundance in the
Golgi membranes and endosomes. In ER, through a
hydrophobic interaction, the E5 protein would stably
associate with 16 kDa subunit of V-ATPase, preventing its
assembly into the mature form and therefore suppressing
the endosomal acidification [11]. However there is no
generalized consent on this mechanism and other
authors, based on the failure to induce V-ATPase inhibi-
tion in some models [44] and on the report that E5 dis-
rupts actin filaments in fibroblasts [23], proposed that E5-
mediated suppression of the endosomal acidification
occurs through the disruption of the membrane traffick-
ing responsible for the fusion of early endosomes with the
highly acidic mature para-nuclear endosomes[23]. More-
over other E5 indirect mechanisms may be hypothesised
based on its complex modulation of cell proteome and
membrane lipids and proteins composition [45-47].
Following the infection with a retrovirus construct bearing
the HPV-16 E5 sequence, the E5 specific mRNA could be
consistently detected in FRM and M14 cells up to thirty
days post infection. The E5 viral specific mRNA was
expressed at a level comparable with the one of the
GAPDH housekeeping reference gene. The E5 expression
was well tolerated with almost no cytotoxic effect and no
modification of cell morphology. Expectedly, as revealed
by experiments with AO, the E5 expression was associated
with a relevant modification of the endocellular pH and
with a neat re-activation of the tyrosinase enzyme. These
data are in favour of the hypothesis that E5 protein does
indeed act through an interaction with 16 kDa subunit c
of the V0-ATPase sub-complex. In fact, in amelanotic
melanomas the most of tyrosinase and of other melano-
genic proteins, instead of being transported to the Golgi
and endosomes for further processing and glicosilation,
due to the acidic environment, are retained in the ER
where they are rapidly degraded by proteasome [48]. Con-
versely, the maturation of tyrosinase to the enzymatically
active form (figure 4b) indicate the elevation of the endo-
cellular pH to a near neutral value following the V-ATPase
complex inhibition thus supporting the hypothesis of an
interaction of the E5 with the 16 kDa sub unit c. This
interaction could reasonably occurs in the ER where the
Tyrosinase activity in FRM and M14 melanoma cells under  control conditions, in cells treated with ConA and in HPV-16  E5 expressing cells Figure 5
Tyrosinase activity in FRM and M14 melanoma cells 
under control conditions, in cells treated with ConA 
and in HPV-16 E5 expressing cells. Tyrosinase activity 
was measured in FRM and M14 melanoma control cells 
(CTR), in cells treated with ConA (+ ConA) and in HPV-16 
E5 expressing cells (+ E5). Cells were lysed by sonication as 
described in Materials and Methods, Enzymatic activity was 
assayed by measuring the amount of [3H] labelled water pro-
duced after incubation for 2 h at 37°C in reaction buffer con-
taining [3H] tyrosine. Results are given as nmoles [3H]2O 
formed/h/mg protein. The mean ± SD of four independent 
experiments are depicted. Statistical comparison was made 
using the non parametric Mann – Whitney test. (*) = p < 
0.05; (**) = p < 0.005. CTR cells did not show enzyme activ-
ity. Treatment with V-ATPase inhibitor or E5 expression 
restored the catalytic activity of the enzyme with the E5 
oncogene associated with higher levels of activity.
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16 kDa V-ATPase subunit is synthesized and where most
of E5 is localized. However we could not provide a posi-
tive evidence for a direct interaction and, considering the
multifaceted cellular effects of E5, other indirect mecha-
nisms may be envisioned. Namely the modifications of
membrane lipids compositions and functions [45,46] and
the deep modifications of cell transcriptome [47], both
obtained in HaCaT cells, have the potentials, either alone
or in combination, to modulate the proteins and organel-
lar functions without implying any direct physical E5/sub-
unit c interaction.
The E5 expressing cells proved able to sustain the melanin
deposition and to survive in anchorage independent cul-
ture conditions (figure 4c) thus confirming and extending
the observation on mouse embryo fibroblasts [17] and
human epithelial HaCaT cells [49] already reported.
According to Zhang et al [37], these two features are asso-
ciated with a reduced growth ability and represent the
hallmark of melanomas adapted to grow in well oxygen-
ated tissues. Conversely, a high growth rate, the ability to
grow in adherence as in compact lesions and the lack of
pigmentary activity (as a consequence of the environment
acidification due to the high levels of glycolytic activity -
the Warburg effect-), are typical of those melanomas
adapted to grow in highly hypoxic condition of fast grow-
ing metastases. In this perspective the discussed results are
consistent with the hypothesis of a more differentiated
phenotype. Indeed following E5 expression and the resto-
ration of a near neutral pH, in addition to the correct mat-
uration of tyrosinase, a global re-organization of the
endocellular trafficking occurs. Such a reorganization per-
mits the adequate processing of the many pigmentary pro-
teins through several different pathways and their correct
cooperation into the multi-step process of pigment depo-
sition. As a whole these data stand against the hypothesis
that the E5 alkalinisation of cellular pH takes place
through the subversion of endocellular trafficking, which
is on the contrary restored, at least as far as melanogenesis
is concerned. Conversely they support the view that the E5
protein, once expressed in an intact human cell, directly or
indirectly modulates V-ATPase proton pump with a wide
range of orchestrated functional consequences. Finally
restoration of the melanogenic phenotype is associated
with a clear elevation of cell reducing activity, consistent
with a partially re-differentiated phenotype. Once again
this result is in line with the hypothesis of a close linkage
Expression of HPV-16 E5 oncogene does not affect tyrosi- nase mRNA transcription and protein expression levels Figure 6
Expression of HPV-16 E5 oncogene does not affect 
tyrosinase mRNA transcription and protein expres-
sion levels. Tyrosinase mRNA levels were evaluated by RT-
PCR in FRM and M14 melanoma control cells (CTR), in cells 
treated with 20 nM Con-A (+ ConA) and in cell expressing 
the HPV-16 E5 (+ E5). Panel a) – Total mRNA (1 μg) was 
reverse transcribed and amplified with HuTyr-1/HuTyr-2. 
Four independent experiments gave similar results. All the 
samples showed similar levels of tyrosinase mRNA. Western 
blot analysis (panel b) and densitometric quantisation (panel 
c) of the chemo-luminescent signals of tyrosinase protein lev-
els. No protein modulation was observed under any experi-
mental condition. Results represent the mean ± standard 
deviation (SD) of four independent experiments. (A.U. = 
Arbitrary Unit).
Effect of HPV-16 E5 expression on the sensitivity of  melanoma cells to the tyrosine related antiblastic agents Figure 7
Effect of HPV-16 E5 expression on the sensitivity of 
melanoma cells to the tyrosine related antiblastic 
agents. M14 control cells (grey bars) or HPV-16 E5 express-
ing cells (black bars) were incubated with DHBA (up) or BSO 
(down) at a 30 μM concentration. After 48 h incubation, the 
cell number was determined using the CV assay as described 
in the methods section. The E5 expression is associated with 
a marked sensitivity of melanoma cells to the named anti-
tumour agents. Similar results were obtained with FRM cells 
(data not shown). Reported values are expressed as A540 and 
are the mean ± SD. of eight independent replicas of a repre-
sentative experiment in a set of four. Statistical comparison 
was made using the non parametric Mann – Whitney test * p 
< 0.05; ** p < 0.005.Journal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
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between the global melanoma phenotype and the cell
metabolism which impacts on growth abilities, pathways
activation and pigment deposition [36,37].
Being the anaplastic phenotype of melanomas associated
with a less favourable clinical outcome and a more severe
prognosis [40], we next wondered whether such a rever-
sion could have an impact on response to chemothera-
peutic agents. In this work we showed that following the
inhibition of V-ATPase by HPV16-E5 the whole melanin
synthesis pathway is restored in amelanotic melanoma
lines and accordingly these cells appear more responsive
to dopamine-mimetic pro-drugs, whose toxicity is related
to their oxidation into toxic intermediates i.e. quinones,
by tyrosinase-catalyzed reactions. In addition, tyrosinase
reactivation is also linked with an increased sensitivity to
drugs interacting with other related pathways, as shown
by the case of BSO, a GSH depleting drug via the gamma-
glutamyl-cysteine synthetase inhibition. Since GSH is a
major defence against toxic quinone intermediates
through the production of conjugates, GSH depletion
results in a severe cell death selectively in those cells where
active melanogenesis is present.
In conclusion the expression of the HPV16-E5 oncogene
proved able to (partially) revert the malignant phenotype
of amelanotic melanomas to a less aggressive, drug
responsive state.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
FDD prepared the viral strains and conduced the molecu-
lar analysis and helped in coordinating the work. CF par-
ticipated in data analysis and interpretation and in
manuscript preparation. CB and MP have been involved
in western blot analysis, enzymatic assays and data inter-
pretation. FP and SM participated in cell culture and cel-
lular work and helped with viral strain preparation. CC
participated in study design and critical revision of the
manuscript. RC participated in the study design and coor-
dination and helped to revise the manuscript. FDM con-
ceived of the study, participated in its design and
coordination, has been involved in data analysis and
interpretation and helped to draft the manuscript. All
authors read and approved the final manuscript.
Acknowledgements
This study was supported in part by a grant from the Ministry of Health of 
Italy. The authors would like to thank Dr Gary Sibbett (The Beatson Insti-
tute for Cancer Research, Glasgow, UK) for having kindly provided the 
plasmids for retrovirus production, Dr Gabriella Zupi (Regina Elena Cancer 
Institute) for having kindly supplied the M14 and FRM cell lines, Dr. Daniela 
Di Sciullo, Mr. Vincenzo Peresempio for their skilled technical assistance. 
Dr Irene Terrenato for her help with statistical work and Dr Marco Ravaioli 
for linguistic revision of the manuscript.
References
1. zur Hausen H: Papillomavirus infections–a major cause of
human cancers.  Biochim Biophys Acta 1996, 1288:F55-78.
2. zur Hausen H: Papillomaviruses and cancer: from basic studies
to clinical application.  Nat Rev Cancer 2002, 2:342-50.
3. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and
E7 genes of the human papillomavirus type 16 together are
necessary and sufficient for transformation of primary
human keratinocytes.  J Virol 1989, 63:4417-21.
4. Thomas M, Pim D, Banks L: The Role of HPV E6 Oncoprotein in
Malignant Progression.  In Papillomavirus Research – From natural
history to Vaccines and Beyond Edited by: Campo MS. Norfolk: Caister
Academic Press; 2006:115-132. 
5. McCance DJ: The Biology of the E7 Protein of HPV16.  In Papil-
lomavirus Research – From natural history to Vaccines and Beyond Edited
by: Campo MS. Norfolk: Caister Academic Press; 2006:133-144. 
6. Leptak C, Ramon y Cajal S, Kulke R, Horwitz BH, Riese DJ 2nd, Dotto
GP, DiMaio D: Tumorigenic transformation of murine kerati-
nocytes by the E5 genes of bovine papillomavirus type 1 and
human papillomavirus type 16.  J Virol 1991, 65:7078-83.
7. Bouvard V, Matlashewski G, Gu ZM, Storey A, Banks L: The human
papillomavirus type 16 E5 gene cooperates with the E7 gene
to stimulate proliferation of primary cells and increases viral
gene expression.  Virology 1994, 203:73-80.
8. Valle GF, Banks L: The human papillomavirus (HPV)-6 and
HPV-16 E5 proteins co-operate with HPV-16 E7 in the trans-
formation of primary rodent cells.  J Gen Virol 1995, 76:1239-45.
9. Bravo IG, Alonso A: Mucosal Human Papillomaviruses Encode
Four Different E5 Proteins Whose Chemistry and Phylogeny
Correlate with Malignant or Benign Growth.  J Virology 2004,
78:13613-13626.
10. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rod-
riguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M,
Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle
PE, Burk RD: The carcinogenicity of human papillomavirus
types reflects viral evolution.  Virology 2005, 337:76-84.
11. Conrad M, Bubb VJ, Schlegel R: The human papillomavirus type
6 and 16 E5 proteins are membrane-associated proteins
which associate with the 16-kilodalton pore-forming protein.
J Virol 1993, 67:6170-8.
12. Crusius K, Auvinen E, Steuer B, Gaissert H, Alonso A: The human
papillomavirus type 16 E5-protein modulates ligand-depend-
ent activation of the EGF receptor family in the human epi-
thelial cell line HaCaT.  Exp Cell Res 1998, 241:76-83.
13. Gu Z, Matlashewski G: Effect of human papillomavirus type 16
oncogenes on MAP kinase activity.  J Virol 1995, 69:8051-6.
14. Chen SL, Mounts P: Transforming activity of E5a protein of
human papillomavirus type 6 in NIH 3T3 and C127 cells.  J
Virol 1990, 64:3226-33.
15. Ashrafi GH, Haghshenas MR, Marchetti B, O'Brien PM, Campo MS:
E5 protein of human papillomavirus type 16 selectively
downregulates surface HLA class I.  Int J Cancer 2005,
113:276-83.
16. Zhang B, Li P, Wang E, Brahmi Z, Dunn KW, Blum JS, Roman A: The
E5 protein of human papillomavirus type 16 perturbs MHC
class II antigen maturation in human foreskin keratinocytes
treated with interferon-gamma.  Virology 2003, 310:100-8.
17. Suprynowicz FA, Disbrow GL, Simic V, Schlegel R: Are transform-
ing properties of the bovine papillomavirus E5 protein
shared by E5 from high-risk human papillomavirus type 16?
Virology 2005, 332:102-13.
18. Rodriguez MI, Finbow ME, Alonso A: Binding of human papillo-
mavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the
vacuolar H+-ATPase can be dissociated from the E5-medi-
ated epidermal growth factor receptor overactivation.  Onco-
gene 2000, 19:3727-32.
19. Graham LA, Powell B, Stevens TH: Composition and assembly of
the yeast vacuolar H(+)-ATPase complex.  J Exp Biol 2000,
203:61-70.
20. Straight SW, Hinkle PM, Jewers RJ, McCance DJ: The E5 oncopro-
tein of human papillomavirus type 16 transforms fibroblasts
and effects the downregulation of the epidermal growth fac-
tor receptor in keratinocytes.  J Virol 1993, 67:4521-32.
21. Straight SW, Herman B, McCance DJ: The E5 oncoprotein of
human papillomavirus type 16 inhibits the acidification of
endosomes in human keratinocytes.  J Virol 1995, 69:3185-92.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Experimental & Clinical Cancer Research 2009, 28:4 http://www.jeccr.com/content/28/1/4
Page 12 of 12
(page number not for citation purposes)
22. Adam JL, Briggs MW, McCance DJ: A mutagenic analysis of the
E5 protein of human papillomavirus type 16 reveals that E5
binding to the vacuolar H+-ATPase is not sufficient for bio-
logical activity, using mammalian and yeast expression sys-
tems.  Virology 2000, 272:315-25.
23. Thomsen P, van Deurs B, Norrild B, Kayser L: The HPV16 E5
oncogene inhibits endocytic trafficking.  Oncogene 2000,
19:6023-32.
24. Ancans J, Tobin DJ, Hoogduijn MJ, Smit NP, Wakamatsu K, Thody AJ:
Melanosomal pH controls rate of melanogenesis, eumelanin/
phaeomelanin ratio and melanosome maturation in melano-
cytes and melanoma cells.  Exp Cell Res 2001, 268:26-35.
25. Fuller BB, Spaulding DT, Smith DR: Regulation of the catalytic
activity of preexisting tyrosinase in black and Caucasian
human melanocyte cell cultures.  Exp Cell Res 2001,
262:197-208.
26. Ancans J, Thody AJ: Activation of melanogenesis by vacuolar
type H(+)-ATPase inhibitors in amelanotic, tyrosinase posi-
tive human and mouse melanoma cells.  FEBS Lett 2000,
478:57-60.
27. De Marco F, Perluigi M, Marcante ML, Coccia R, Foppoli C, Blarzino
C, Rosei MA: Cytotoxicity of dopamine-derived tetrahydroi-
soquinolines on melanoma cells.  Biochem Pharmacol 2002,
64:1503-12.
28. Bowman EJ, Siebers A, Altendorf K: Bafilomycins: a class of inhib-
itors of membrane ATPases from microorganisms, animal
cells, and plant cells.  Proc Natl Acad Sci USA 1988, 85:7972-6.
29. Drose S, Bindseil KU, Bowman EJ, Siebers A, Zeeck A, Altendorf K:
Inhibitory effect of modified bafilomycins and concanamy-
cins on P- and V-type adenosinetriphosphatases.  Biochemistry
1993, 32:3902-6.
30. Ashrafi GH, Tsirimonakis E, Marchetti B, O'Brien P, Sibbet GJ,
Andrew L, Campo MS: Down-regulation of MHC class I by
bovine papillomavirus E5 oncoproteins.  Oncogene 2002,
21:248-259.
31. Mann R, Mulligan RC, Baltimore D: Construction of a retrovirus
packaging mutant and its use to produce helper-free defec-
tive retrovirus.  Cell 1983, 33:153-9.
32. Calogero A, Timmer-Bosscha H, Schraffordt Koops H, Tiebosch AT,
Mulder NH, Hospers GA: Limitations of the nested reverse
transcriptase polymerase chain reaction on tyrosinase for
the detection of malignant melanoma micrometastases in
lymph nodes.  Br J Cancer 2000, 83:184-7.
33. Gerlier D, Thomasset N: Use of MTT colorimetric assay to
measure cell activation.  J Immunol Methods 1986, 94:57-63.
34. De Marco F, Di Lonardo A, Venuti A, Marcante ML: Interferon inhi-
bition of neoplastic phenotype in cell lines harbouring
human papillomavirus sequences.  J Biol Regul Homeost Agents
1991, 5:65-70.
35. Palmgren MG: Acridine orange as a probe for measuring pH
gradients across membranes: mechanism and limitations.
Anal Biochem 1991, 192:316-21.
36. Foppoli C, De Marco F, Blarzino C, Perluigi M, Cini C, Coccia R: Bio-
logical response of human diploid keratinocytes to quinone-
producing compounds: role of NAD(P)H:quinone oxidore-
ductase 1.  Int J Biochem Cell Biol 2005, 37:852-63.
37. Iozumi K, Hoganson GE, Pennella R, Everett MA, Fuller BB: Role of
tyrosinase as the determinant of pigmentation in cultured
human melanocytes.  J Invest Dermatol 1993, 100:806-11.
38. Halaban R: Pigmentation in melanomas: Changes manifesting
underlying oncogenic and metabolic activities.  Oncol Res 2002,
13:3-8.
39. Zhang W, Tsan R, Nam DH, Lu W, Fidler IJ: Loss of adhesion in
the circulation converts amelanotic metastatic melanoma
cells to melanotic by inhibition of AKT.  Neoplasia 2006,
8:543-50.
40. Prezioso JA, Fitzgerald GB, Wick MM: Effects of tyrosinase activ-
ity on the cytotoxicity of 3,4-dihydroxybenzylamine and
buthionine sulfoximine in human melanoma cells.  Pigment Cell
Res 1990, 3:49-54.
41. Orlow SJ, Silvers WK, Zhou BK, Mintz B: Comparative decreases
in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic
proteins from melanotic to amelanotic stages of syngeneic
mouse cutaneous melanomas and metastases.  Cancer Res
1998, 58:1521-3.
42. Takeuchi H, Kuo C, Morton DL, Wang HJ, Hoon DS: Expression of
differentiation melanoma-associated antigen genes is associ-
ated with favorable disease outcome in advanced-stage
melanomas.  Cancer Res 2003, 63:441-8.
43. DiMaio D, Mattoon D: Mechanisms of cell transformation by
papillomavirus E5 proteins.  Oncogene 2001, 20:7866-73.
44. Ashby AD, Meagher L, Campo MS, Finbow ME: E5 transforming
proteins of papillomaviruses do not disturb the activity of
the vacuolar H(+)-ATPase.  J Gen Virol 2001, 82:2353-62.
45. Bravo IG, Crusius K, Alonso A: The E5 protein of the human
papillomavirus type 16 modulates composition and dynam-
ics of membrane lipids in keratinocytes.  Arch Virol 2005,
150:231-46.
46. Suprynowicz FA, Disbrow GL, Krawczyk E, Simic V, Lantzky K, Sch-
legel R: HPV-16 E5 oncoprotein upregulates lipid raft compo-
nents caveolin-1 and ganglioside GM1 at the plasma
membrane of cervical cells.  Oncogene 2008, 27:1071-1078.
47. Kivi N, Greco D, Auvinen P, Auvinen E: Genes involved in cell
adhesion, cell motility and mitogenic signaling are altered
due to HPV 16 E5 protein expression.  Oncogene 2008,
27:2532-41.
48. Watabe H, Valencia JC, Yasumoto K, Kushimoto T, Ando H, Muller J,
Vieira WD, Mizoguchi M, Appella E, Hearing VJ: Regulation of tyro-
sinase processing and trafficking by organellar pH and by
proteasome activity.  J Biol Chem 2004, 279:7971-81.
49. Lewis C, Baro MF, Marques M, Grüner M, Alonso A, Bravo IG: The
first hydrophobic region of the HPV16 E5 protein deter-
mines protein cellular location and facilitates anchorage-
independent growth.  Virol J 2008, 5:30.